Ensysce Biosciences Inc.

5.38
0.13 (2.48%)
At close: Feb 28, 2025, 3:59 PM
5.39
0.19%
After-hours: Feb 28, 2025, 04:00 PM EST

Ensysce Biosciences Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 2.23M 2.52M 3.53M 3.93M 1.76M n/a n/a
Cost of Revenue 7.59M 19.84M 151.00 1.37M 3.33M 1.56M n/a
Gross Profit -5.36M -17.31M 3.53M 2.56M -1.56M -1.56M n/a
Operating Income -10.72M -24.22M -19.87M -1.61M -3.33M -959.24K -146.7K
Interest Income n/a 1.25M 3.22M 719.65K 4.25M 3.63M n/a
Pretax Income -10.63M -24.21M -29.15M -160.88K 921.15K 2.68M -27.56K
Net Income -10.61M -24.96M -29.15M -938.73K 1.48M -1.34M -31.19K
Selling & General & Admin 5.36M 6.91M 18.71M 1.15M 3.33M 1.56M 146.69K
Research & Development 7.59M 19.84M 4.69M 4.39M 3.4M n/a n/a
Other Expenses -7.59M -2.52M -3.53M -3.93M n/a 600K n/a
Operating Expenses 5.36M 24.22M 19.87M 1.61M 3.33M 959.25K 146.69K
Interest Expense 353.94K 109.53K 1.3M 995.5K n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a -3.6M n/a n/a
Cost & Expenses 12.95M 24.22M 19.87M 1.61M 3.33M 959.24K 146.69K
Income Tax n/a 753.88K -151 777.85K -555.2K 553.92K 3.63K
Shares Outstanding (Basic) 2.26M 179.93K 84.02K 65.7K 98.26K 104.02K 105K
Shares Outstanding (Diluted) 2.26M 179.93K 84.02K 68.78K 98.26K 104.02K 105K
EPS (Basic) -4.69 -138.73 -346.9 -14.29 15.02 -12.91 -0.3
EPS (Diluted) -4.69 -138.73 -346.9 -13.65 15.02 -12.91 -0.3
EBITDA -10.72M -24.22M -19.87M -1.61M 921.15K 2.68M -27.55K
Depreciation & Amortization -3 151.00 151.00 201.00 201.00 161.14K n/a